Author:
Aghajanian Haig,Kimura Toru,Rurik Joel G.,Hancock Aidan S.,Leibowitz Michael S.,Li Li,Scholler John,Monslow James,Lo Albert,Han Wei,Wang Tao,Bedi Kenneth,Morley Michael P.,Linares Saldana Ricardo A.,Bolar Nikhita A.,McDaid Kendra,Assenmacher Charles-Antoine,Smith Cheryl L.,Wirth Dagmar,June Carl H.,Margulies Kenneth B.,Jain Rajan,Puré Ellen,Albelda Steven M.,Epstein Jonathan A.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E. & Blaxall, B. C. Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118, 1021–1040 (2016).
2. Kong, P., Christia, P. & Frangogiannis, N. G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 71, 549–574 (2014).
3. Fang, L., Murphy, A. J. & Dart, A. M. A clinical perspective of anti-fibrotic therapies for cardiovascular disease. Front. Pharmacol. 8, 186 (2017).
4. Ottaviano, F. G. & Yee, K. O. Communication signals between cardiac fibroblasts and cardiac myocytes. J. Cardiovasc. Pharmacol. 57, 513–521 (2011).
5. Fan, Z. & Guan, J. Antifibrotic therapies to control cardiac fibrosis. Biomater. Res. 20, 13 (2016).
Cited by
474 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献